Anemia and iron deficiency in COPD patients: Prevalence and the effects of correction of the anemia with erythropoiesis stimulating agents and intravenous iron

BMC Pulmonary Medicine

Volumn 14, Issue 1, 2014, Pages

  Silverberg, Donald S ^a   Mor, Ram ^a   Weu, Melanie T ^b   Schwartz, Doron ^a   Schwartz, Idit F ^a   Chernin, Gil ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE YOPOUGON   (Côte d’Ivoire)

Author keywords

Anemia; COPD; Erythropoietin; Iron deficiency; Renal failure

Indexed keywords

ANTIANEMIC AGENT; HEMOGLOBIN; IRON; TRANSFERRIN;

AGED; ANEMIA; ARTICLE; CHRONIC KIDNEY DISEASE; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; DYSPNEA; END STAGE RENAL DISEASE; FEMALE; FERRITIN BLOOD LEVEL; FOLLOW UP; HEMATOCRIT; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; IRON BLOOD LEVEL; IRON DEFICIENCY; IRON THERAPY; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR HEMOGLOBIN; MEAN CORPUSCULAR VOLUME; MEDICAL HISTORY; MEDICAL RECORD; OUTPATIENT; OXYGEN SATURATION; PREVALENCE; PULSE OXIMETRY; RETROSPECTIVE STUDY; VISUAL ANALOG SCALE;

AGED; ANEMIA; DEFICIENCY DISEASES; FEMALE; HEMATINICS; HUMANS; INJECTIONS, INTRAVENOUS; IRON; MALE; PREVALENCE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RETROSPECTIVE STUDIES;

EID: 84896728230     PISSN: None     EISSN: 14712466     Source Type: Journal    
DOI: 10.1186/1471-2466-14-24     Document Type: Article

References (63)

1. John M, Hoernig S, Doehner W, Okonko DD, Witt C, Anker SD. Anemia and inflammation in COPD. Chest 2005, 127:825-829. 10.1378/chest.127.3.825, 15764763.
2. Ershler WB, Chen K, Reyes EB, Dubois R. Economic burden of patients with anemia in selected diseases. Value Health 2005, 8:629-638. 10.1111/j.1524-4733.2005.00058.x, 16283863.
3. Chambellan A, Chailleux E, Similowski T, ANTADIR Observatory Group Prognostic value of the hematocrit in patients with severe COPD receiving long-term oxygen therapy. Chest 2005, 185:1201-1208. ANTADIR Observatory Group.
4. Krishnan G, Grant BJ, Muti PC, Mishra A, Ochs-Balcom HM, Freudenheim JL, Trevisan M, Schünemann HJ. Association between anemia and quality of life in a population sample of individuals with chronic obstructive pulmonary disease. BMC Pulm Med 2006, 5(6):23.
5. Cote C, Zilberberg MD, Mody SH, Dordelly LJ, Celli B. Hemoglobin level and its clinical impact in a cohort of patients with COPD. Eur Respir J 2007, 29:923-929. 10.1183/09031936.00137106, 17251227.
6. Halpern MT, Zilberberg MD, Schmier JK, Lau EC, Schorr AF. Anemia, costs and mortality in chronic obstructive pulmonary disease. Cost eff Resour Alloc 2006, 4:17-24. 10.1186/1478-7547-4-17, 1633732, 17042950.
7. John M, Lange A, Hoernig S, Witt C, Anker SD. Prevalence of anemia in chronic obstructive pulmonary disease: comparison to other chronic diseases. Int J Cardiol 2006, 111:365-370. 10.1016/j.ijcard.2005.07.043, 16242192.
8. Martinez FJ, Foster G, Curtis JL, Criner G, Weinmann G, Fishman A, DeCamp MM, Benditt J, Sciurba F, Make B, Mohsenifar Z, Diaz P, Hoffman E, Wise R, NETT Research Group Predictors of mortality in patients with emphysema and severe airflow obstruction. Am J Resp Crit Care Med 2006, 173:1326-1334. 10.1164/rccm.200510-1677OC, 2662972, 16543549, NETT Research Group.
9. Copur AS, Fulambarker A, Molnar J, Nadeem R, McCormack C, Ganesh A, Kheir F, Hamon S. Role of anemia in home oxygen therapy in chronic obstructive pulmonary disease patients. Am J Ther 2013, Apr 5. (Epub ahead of print].
10. Shorr AF, Doyle J, Stern L, Dolgister M, Zilberberg MD. Anemia in chronic pulmonary disease: epidemiology and economic implications. Curr Med Res Opin 2008, 24:1123-1130. 10.1185/030079908X280699, 18331668.
11. Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Resp J 2009, 33:1165-1185.
12. Cosio MG, Saetta M, Agusti A. Immunologic aspects of chronic obstructive pulmonary disease. NEJM 2009, 360:2445-2454. 10.1056/NEJMra0804752, 19494220.
13. Kollert F, Müller C, Tippelt A, Jörres RA, Heidinger D, Probst C, Pfeifer M, Budweiser S. Anaemia in chronic respiratory failure. Int J Clin Pract 2011, 65:479-486. 10.1111/j.1742-1241.2011.02631.x, 21401836.
14. Kollert F, Tippelt A, Müller C, Jörres RA, Porzelius C, Pfeifer M, Budweiser S. Hemoglobin levels above anemia thresholds are maximally predictive for long-term survival in COPD with chronic respiratory failure. Respir Care 2012, Dec 4. [Epub ahead of print].
15. Boutou AK, Karrar S, Hopkinson NS, Polkey MI. Anemia and survival in chronic obstructive pulmonary disease: a dichotomous rather than a continuous predictor. Respiration 2013, 85:126-131. 10.1159/000338792, 22759351.
16. Boutou AK, Stanopoulos I, Pitsiou GG, Kontakiotis T, Kyriazis G, Sichletidis L, Argyropoulou P. Anemia of chronic disease in chronic obstructive pulmonary disease: a case-control study of cardiopulmonary exercise responses. Respiration 2011, 82:237-245. 10.1159/000326899, 21576921.
17. Nemeth E. Iron regulation and erythropoiesis. Curr Opin Hematol 2008, 15:169-175. 10.1097/MOH.0b013e3282f73335, 18391780.
18. Theurl I, Aigner E, Theurl M, Nairz M, Seifert M, Schroll A, Sonnweber T, Eberwein L, Witcher DR, Murphy AT, Wroblewski VJ, Wurz E, Datz C, Weiss G. Regulation of iron homeostasis in anemia of chronic disease and iron deficiency anemia: diagnostic and therapeutic implications. Blood 2009, 113:5277-5286. 10.1182/blood-2008-12-195651, 19293425.
19. McKeever TM, Lewis SA, Smit HA, Burney P, Cassano PA, Britton J. A multivariate analysis of serum nutrient levels and lung function. Respir Res 2008, 9:67. 10.1186/1465-9921-9-67, 2565672, 18823528.
20. Obase Y, Mouri K, Shimizu H, Ohue Y, Kobashi Y, Kawahara K, Oka M. Nutritional deficits in elderly smokers with respiratory symptoms that do not fulfill the criteria for COPD. Int J Chron Obstruct Pulmon Dis 2011, 6:679-683. 3257953, 22259244.
21. Silverberg DS, Wexler D, Blum M, Keren G, Sheps D, Leibovitch E, Brosh D, Laniado S, Schwartz D, Yachnin T, Shapira I, Gavish D, Baruch R, Koifman B, Kaplan C, Steinbruch S, Iaina A. The use of subcutaneous erythropoietin and intravenous iron for the treatment of the anemia of severe, resistant congestive heart failure improves cardiac and renal function and functional cardiac class, and markedly reduces hospitalizations. J Am Coll Cardiol 2000, 35:1737-1744. 10.1016/S0735-1097(00)00613-6, 10841219.
22. Silverberg DS, Wexler D, Sheps D, Blum M, Keren G, Baruch R, Schwartz D, Yachnin T, Steinbruch S, Shapira I, Laniado S, Iaina A. The effect of correction of mild anemia in severe, resistant congestive heart failure using subcutaneous erythropoietin and intravenous iron: a randomized controlled study. J Am Coll Cardiol 2001, 37:1775-1780. 10.1016/S0735-1097(01)01248-7, 11401110.
23. Jankowska EA, von Haehling S, Anker SD, Macdougall IC, Ponikowski P. Iron deficiency and heart failure: diagnostic dilemmas and therapeutic perspectives. Eur Heart J 2013, 34:816-829. 10.1093/eurheartj/ehs224, 3596759, 23100285.
24. Levey AS, Bosch JP, Lewis JB, Greene T, Rogers N, Roth D. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of diet in renal disease study group. Ann Intern Med 1999, 130:461-470. 10.7326/0003-4819-130-6-199903160-00002, 10075613.
25. American Thoracic Society Standardization of spirometry, 1994 update. Am J Respir Crit Care Med 1995, 152:1107-1136. American Thoracic Society.
26. Portillo K, Martinez-Rivera C, Ruiz-Manzano J. Anaemia in chronic obstructive pulmonary disease. Does it really matter?. Int J Clin Pract 2013, 67:558-565. 10.1111/ijcp.12125, 23679907.
27. Portillo K, Belda J, Antón P, Casan P. High frequency of anemia in COPD patients admitted in a tertiary hospital. Rev Clin Esp 2007, 207:383-387. 10.1157/13108755, 17688864.
28. Martinez-Rivera C, Portillo K, Muñoz-Ferrer A, Martínez-Ortiz ML, Molins E, Serra P, Ruiz-Manzano J, Morera J. Anemia is a mortality predictor in hospitalized patients for COPD exacerbation. COPD 2012, 9:243-250. 10.3109/15412555.2011.647131, 22360381.
29. Comeche Casanova L, Echave-Sustaeta JM, García Luján R, Albarrán Lozano I, Alonso González P, Llorente Alonso MJ. Prevalence of anaemia associated with chronic obstructive pulmonary disease. Study of associated variables. Arch Bronconeumol 2013, 49:383-387.
30. Creutzberg EC, Wouters EF, Mostert R, Pluymers RJ, Schols AM. A role for anabolic steroids in the rehabilitation of patients with COPD? A double blind placebo controlled randomized trial. Chest 2003, 134:1733-1743.
31. Schonhofer B, Wenzel M, Geibel M, Kohler D. Blood transfusion and lung function in chronically anemic patients with severe chronic obstructive sleep pulmonary disease. Crit Care Med 1998, 26:1824-1828. 10.1097/00003246-199811000-00022, 9824074.
32. Schonhofer B, Bohrer H, Kohler D. Blood transfusion facilitating difficulty meaning from ventilator. Anaesthesia 1998, 53:181-184. 10.1046/j.1365-2044.1998.00275.x, 9534644.
33. Similowski T, Agustí A, MacNee W, Schönhofer B. The potential impact of anaemia of chronic disease in COPD. Eur Respir J 2006, 27:390-396. 10.1183/09031936.06.00143704, 16452598.
34. Boutou AK, Pitsiou GG, Stanopoulos I, Kontakiotis T, Kyriazis G, Argyropoulou P. Levels of inflammatory mediators in chronic obstructive pulmonary disease patients with anemia of chronic disease: a case-control study. QJM 2012, 105:657-663. 10.1093/qjmed/hcs024, 22355163.
35. Markoulaki D, Kostikas K, Papatheodorou G, Koutsokera A, Alchanatis M, Bakakos P, Gourgoulianis KI, Roussos C, Koulouris NG, Loukides S. Hemoglobin, erythropoietin and systemic inflammation in exacerbations of chronic obstructive pulmonary disease. Eur J Intern Med 2011, 22:103-107. 10.1016/j.ejim.2010.07.010, 21238904.
36. Edwards LD, Rennard SI, MacNee W, Tal- Singer R, Miller BE, Vestbo J, Lomas DA, Calverley PM, Wouters E, Crim C, Yates JC, Silverman EK, Coxson HO, Bakke P, Mayer RJ, Celli B, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012, 7:e37483. 10.1371/journal.pone.0037483, 3356313, 22624038, Evaluation of COPD Longitudinally to Identify Predictive Surrogate Endpoints (ECLIPSE) Investigators.
37. Babitt JL, Lin HY. Mechanisms of anemia in CKD. J Am Soc Nephrol 2012, 23:1631-1634. 10.1681/ASN.2011111078, 3458456, 22935483.
38. Leshem-Rubinow E, Steinvil A, Zeltser D, Berliner S, Rogowski O, Raz R, Chodick G, Shalev V. Association of angiotensin-converting enzyme inhibitor therapy initiation with a reduction in hemoglobin levels in patients without renal failure. Mayo Clin Proc 2012, 87:1189-1195. 10.1016/j.mayocp.2012.07.020, 3547548, 23141116.
39. Thomas MC. Anemia in diabetes: marker or mediator of microvascular disease?. Nat Clin Pract Nephrol 2007, 3:20-30.
40. Fischer R, Simmerlein R, Huber RM, Schiffl H, Lang SM. Lung disease severity, chronic inflammation, iron deficiency and transferrin response in adults with cystic fibrosis. Pediatr Pulmonol 2007, 42:1193-1197. 10.1002/ppul.20717, 17948283.
41. Isanaka S, Aboud S, Mugusi F, Bosch RJ, Willett WC, Spiegelman D, Duggan C, Fawzi WW. Iron status predicts treatment failure and mortality in tuberculosis patients: a prospective cohort study from Dar es Salaam, Tanzania. PLoS One 2012, 7:e37350. 10.1371/journal.pone.0037350, 3350480, 22606361.
42. Smith TG, Talbot NP, Privat C, Rivera-Ch M, Nickol AH, Ratcliffe PJ, Dorrington KL, León-Velarde F, Robbins PA. Effects of iron supplementation and depletion on hypoxic pulmonary hypertension: two randomized controlled trials. JAMA 2009, 302:1444-1450. 10.1001/jama.2009.1404, 19809026.
43. Rhodes CJ, Wharton J, Howard L, Gibbs JS, Vonk-Noordegraaf A, Wilkins MR. Iron deficiency in pulmonary arterial hypertension: a potential therapeutic target. Eur Respir J 2011, 38:1453-1460. 10.1183/09031936.00037711, 21478213.
44. Rhodes CJ, Howard LS, Busbridge M, Ashby D, Kondili E, Gibbs JS, Wharton J, Wilkins MR. Iron deficiency and raised hepcidin in idiopathic pulmonary arterial hypertension: clinical prevalence, outcomes, and mechanistic insights. J Am Coll Cardiol 2011, 58:300-309. 10.1016/j.jacc.2011.02.057, 21737024.
45. Ruiter G, Lankhorst S, Boonstra A, Postmus PE, Zweegman S, Westerhof N, van der Laarse WJ, Vonk-Noordegraaf A. Iron deficiency is common in idiopathic pulmonary arterial hypertension. Eur Respir J 2011, 37:1386-1391. 10.1183/09031936.00100510, 20884742.
46. van der Meer P, Groenveld H, Januzzi JL, van Veldhuisen DJ. Erythropoietin treatment in patients with Chronic Heart Failure: a meta-analysis. Heart 2009, 95:1309-1314. 10.1136/hrt.2008.161091, 19168472.
47. Ngo K, Kotecha D, Walters JA, Manzano L, Palazzuoli A, van Veldhuisen DJ, Flather M. Erythropoiesis-stimulating agents for anaemia in chronic heart failure patients. Cochrane Database Syst Rev 2010, 20:CD007613.
48. Lawler PR, Filion KB, Eisenberg MJ. Correcting Anemia in Heart Failure: The Efficacy and Safety of Erythropoiesis-Stimulating Agents. J Cardiac Fail 2010, 16:649-658.
49. Silverberg DS. The role of erythropoiesis stimulating agents and intravenous (IV) iron in the cardio renal anemia syndrome. Heart Fail Rev 2011, 16:609-614. 10.1007/s10741-010-9194-2, 20865450.
50. Zeng Q, Jiang S. Update in diagnosis and therapy of coexistent chronic obstructive pulmonary disease and chronic heart failure. J Thorac Dis 2012, 4:310-315. 3378198, 22754671.
51. McMurray JJ, Anand IS, Diaz R, Maggioni AP, O'Connor C, Pfeffer MA, Solomon SD, Tendera M, van Veldhuisen DJ, Albizem M, Cheng S, Scarlata D, Swedberg K, Young JB, RED-HF Committees Investigators Baseline characteristics of patients in the Reduction of Events with Darbepoetin alfa in Heart Failure trial (RED-HF). Eur J Heart Fail 2013, 15:334-341. 10.1093/eurjhf/hfs204, 3576902, 23329651, RED-HF Committees Investigators.
52. Swedberg K, Young JB, Anand IS, Cheng S, Desai AS, Diaz R, Maggioni AP, McMurray JJ, O'Connor C, Pfeffer MA, Solomon SD, Sun Y, Tendera M, van Veldhuisen DJ, RED-HF Committees; RED-HF Investigators Treatment of anemia with darbepoetin alfa in systolic heart failure. N Engl J Med 2013, 368:1210-1219. 10.1056/NEJMoa1214865, 23473338, RED-HF Committees; RED-HF Investigators.
53. Unger EF, Thompson AM, Blank MJ, Temple R. Erythropoiesis-stimulating agents: time for a reevaluation. N Engl J Med 2010, 362:189-192. 10.1056/NEJMp0912328, 20054037.
54. Goldsmith D. 2009: a requiem for rHuEPOs-but should we nail down the coffin in 2010?. Clin J Am Soc Nephrol 2010, 5:929-935. 10.2215/CJN.09131209, 20413441.
55. Singh AK. Does TREAT give the boot to ESAs in the treatment of CKD anemia?. J Am Soc Nephrol 2010, 21:2-6. 10.1681/ASN.2009111127, 20035034.
56. Besarab A, Hörl WH, Silverberg D. Iron metabolism, iron deficiency, thrombocytosis, and the cardiorenal anemia syndrome. Oncologist 2009, 14(Suppl 1):22-33.
57. Vaziri ND, Zhou XJ. Potential mechanisms of adverse outcomes in trials of anemia correction with erythropoietin in chronic kidney disease. Nephrol Dial Transplant 2009, 24:1082-1088.
58. Anker SD, Comin Colet J, Filippatos G, Willenheimer R, Dickstein K, Drexler H, Lüscher TF, Bart B, Banasiak W, Niegowska J, Kirwan BA, Mori C, von Eisenhart Rothe B, Pocock SJ, Poole-Wilson PA, Ponikowski P, FAIR-HF Trial Investigators Ferric carboxymaltose in patients with heart failure and iron deficiency. N Engl J Med 2009, 361:2436-2448. 10.1056/NEJMoa0908355, 19920054, FAIR-HF Trial Investigators.
59. Van Buren P, Velez RL, Vaziri ND, Zhou XJ. Iron overdose: a contributor to adverse outcomes in randomized trials of anemia correction in CKD. Int Urol Nephrol 2012, 44:499-507. 10.1007/s11255-011-0028-5, 3314165, 21744260.
60. Vaziri ND. Understanding iron: promoting its safe use in patients with Chronic Kidney Failure Treated by Hemodialysis. Am J Kidney Dis 2013, EPub ahead of print.
61. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. Update 2013 [accessed 28.9.2013]. Available from: http://www.goldcopd.org.
62. Locatelli F, Bárány P, Covic A, De Francisco A, Del Vecchio L, Goldsmith D, Hörl W, London G, Vanholder R, Van Biesen W, on behalf of the ERA-EDTA ERBP Advisory Board Kidney disease: improving global outcomes guidelines on anaemia management in chronic kidney disease: a European Renal Best Practice position statement. Nephrol Dial Transplant 2013, Apr 12. [Epub ahead of print], on behalf of the ERA-EDTA ERBP Advisory Board.
63. McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, Falk V, Filippatos G, Fonseca C, Gomez-Sanchez MA, Jaarsma T, Køber L, Lip GY, Maggioni AP, Parkhomenko A, Pieske BM, Popescu BA, Rønnevik PK, Rutten FH, Schwitter J, Seferovic P, Stepinska J, Trindade PT, Voors AA, Zannad F, Zeiher A, Bax JJ, Baumgartner H, Ceconi C, , et al. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur J Heart Fail 2012, 14:803-869. Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology.